The award could rise to several billions under federal antitrust law, after the pharma company was found to have engaged in anticompetitive conduct over constipation drug Amitiza.

In the firm’s second IP conflict dispute in a year, a healthcare tech company claims Kirkland lawyers "committed the cardinal ...

Orrick lands five-member M&A team in Paris ...

AbbVie’s trade secret suit against a Chinese rival gets green light ...

UK govt backs DeepMind spinout’s $2.1bn plan to ‘solve all disease’ with AI ...

Genomics settles suit with rival and targets DNA sequencing startup ...

The risks that bite before, during and after closing ...

21 April 2026 A New Jersey firm appoints the high-stakes litigator as chair of its trademarks, trade secrets and copyright ...

LSIPR's senior reporter Marisa Woutersen speaks with Mythili Markowski of Regeneron on why new USPTO guidance is putting post ...

Panellists at INTA share how workplaces can bridge generational divides and why those differences may be a team’s biggest strengths.

Insurance company Cigna claims Bristol Myers Squibb may have caused overpayments of ‘billions’ of dollars after allegedly delaying market entry of generic Pomalyst | Lawsuit follows dismissal of ...